Eleni Antzoulatos

Eleni Antzoulatos practices at Grady Memorial Hospital in Atlanta, Georgia, part of The Fulton-DeKalb Hospital Authority.

Eleni Antzoulatos' NPI, 1275952137, was assigned on April 8, 2014. Eleni Antzoulatos graduated from New York Medical College in 2014. Eleni Antzoulatos holds Georgia license 88801.

Eleni Antzoulatos' primary practice is Grady Memorial Hospital, at 80 Jesse Hill, Jr Drive SE, Atlanta, GA 30303 in Fulton County. The practice phone is (404) 616-1000.

Eleni Antzoulatos' primary practice is Grady Memorial Hospital in Atlanta, Georgia, part of The Fulton-DeKalb Hospital Authority. The medical group on file is Emory Clinic. Dmand AI also links Eleni Antzoulatos to 2 more group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Eleni Antzoulatos practices, 3 sites in all. Vendor and product names are available with a free account.

Neurology is Eleni Antzoulatos' primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dmand AI has Eleni Antzoulatos' licenses on file in 4 states: Georgia, Alabama, Florida and Ohio.

CMS data shows 158 Medicare services from Eleni Antzoulatos across 5 procedure codes in 2024, for 94 Medicare patients. Medicare paid $13,087 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 94 Medicare patients who saw Eleni Antzoulatos in 2024. The largest group is 65 to 74, with 39 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 45% are also on Medicaid. Their average risk score is 2.34, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Eleni Antzoulatos' median patient age at 69, with 48% women.

In 2024, Eleni Antzoulatos wrote 214 Medicare Part D claims for 72 patients. 87% of them were for generic drugs. CMS names the drug for 47 of them, across 3 drugs with 11 or more claims each, at $332 in total drug cost. In 2023, CMS named 90 claims across 5 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 93 out of 100 for Eleni Antzoulatos for performance year 2024, reported as part of a group. Eleni Antzoulatos accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 5 papers to Eleni Antzoulatos, published from 2010 to 2025. Eleni Antzoulatos' most frequent co-authors are Stacie Leigh Demel, DO, Matthew Leonard Flaherty, MD and Pooja Khatri, MD.

CMS Open Payments shows 4 general payments to Eleni Antzoulatos from 3 drug and device companies from 2017 to 2019. Food and beverage make up the largest share, 100% of the total. Genentech, Inc. paid the most, $205.

Eleni Antzoulatos graduated from New York Medical College in 2014.